At a glance
- Originator FAES Farma
- Class Antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypersensitivity; Respiratory tract disorders
Most Recent Events
- 11 Nov 1996 Discontinued-Preclinical for Allergy in Spain (Unknown route)
- 18 Jan 1996 Discontinued-Preclinical for Respiratory tract disorders in Spain (Unknown route)